COVID-19 Health Evidence Summary No.16

13th April 2020
Author: Kerry Millington

This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government departments to the latest relevant evidence and discourse on COVID-19 to inform and support their response. This summary is a result of 3 hours of work and is not intended to be a comprehensive summary of evidence. This summary covers seven publications on BCG against coronavirus, the gendered dimensions of COVID-19, Neurologic manifestations of hospitalised patients with coronavirus disease 2019 in Wuhan China, the spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infections, compassionate use of remdesivir for patients with severe COVID-19, obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission, and fear of a fragile planet . This summary also covers global evidence on tracking COVID-19 cases, online learning and events, and COVID-19 resource hubs that are accessible by the public.

Download Summary
Suggested Citation

Millington, K.A. (2020). COVID-19 Health Evidence Summary No.16. K4D Evidence Summary. Brighton, UK: Institute of Development Studies.


13th April 2020


Continent: Africa, Global

Country: China, United Kingdom